Rossignol P, Williams B, Mayo MR, Warren S, et al. Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): results in the pre-specified subgroup with heart failure. Eur J Heart Fail 2020 May 25. doi: 10.1002/ejhf.1860.
PMID: 32452085